A
36
2
WDC
41
-2
EQT
59
2
EXC
54
-2
VFC
47
-5
ORLY
53
-3
AFL
46
-3
TEL
60
2
GM
65
-3
DAL
80
-4
DD
56
3
DVA
72
2
IPG
49
10
LUV
39
-5
MRK
22
3
PVH
52
-3
DHI
48
3
HAS
30
2
MAS
51
4
MDLZ
34
2
A
36
2
WDC
41
-2
EQT
59
2
EXC
54
-2
VFC
47
-5
ORLY
53
-3
AFL
46
-3
TEL
60
2
GM
65
-3
DAL
80
-4
DD
56
3
DVA
72
2
IPG
49
10
LUV
39
-5
MRK
22
3
PVH
52
-3
DHI
48
3
HAS
30
2
MAS
51
4
MDLZ
34
2
Financhill
Back

Arbutus Biopharma Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
36

ABUS
Arbutus Biopharma

Last Price:
3.46
Seasonality Move:
15.21%
Buy
57

BMRN
Biomarin Pharmaceutical

Last Price:
63.44
Seasonality Move:
12.47%
Sell
36
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.44. The Score for ABUS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $62.56. The Score for BMRN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $62.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 28.99 Sell
Chaikin Money Flow: -417405 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.64 - 4.06) Sell
Bollinger Bands (100): (3.55 - 4.13) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.16 Sell
Relative Strength Index (14 RSI): 27.46 Sell
Chaikin Money Flow: 863717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.41 - 69.77) Sell
Bollinger Bands (100): (68.48 - 87.38) Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.59 Sell
20-day SMA: 3.79 Sell
50-day SMA: 3.93 Sell
200-day SMA: 3.37 Buy
8-day EMA: 3.59 Sell
20-day EMA: 3.73 Sell
50-day EMA: 3.83 Sell
200-day EMA: 3.43 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.33 Sell
20-day SMA: 66.31 Sell
50-day SMA: 69.39 Sell
200-day SMA: 81.31 Sell
8-day EMA: 63.89 Sell
20-day EMA: 65.94 Sell
50-day EMA: 70.23 Sell
200-day EMA: 79.7 Sell

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):